Critical role for Gab2 in transformation by BCR/ABL

Cancer Cell

Volumn 1, Issue 5, 2002, Pages 479-492

  Sattler, Martin ^a   Mohi, M Golam ^b   Pride, Yuri B ^a   Quinnan, Laura R ^a   Malouf, Nicole A ^a   Podar, Klaus ^a   Gesbert, Franck ^a   Iwasaki, Hiromi ^a   Li, Shaoguang ^a,c   Van Etten, Richard A ^a   Gu, Haihua ^b   Griffin, James D ^a   Neel, Benjamin G ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD INSTITUTES OF MEDICINE   (United States)

^c JACKSON LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; GRB2 PROTEIN, HUMAN; GRB2 PROTEIN, MOUSE; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; GUANOSINE TRIPHOSPHATE; HELMINTH PROTEIN; IMATINIB; MICROFILARIAL SHEATH PROTEIN, HELMINTH; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN; PYRIMIDINE DERIVATIVE; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TYROSINE;

ANIMAL CELL; APOPTOSIS; ARTICLE; AUTOPHOSPHORYLATION; BONE MARROW CELL; CELL MIGRATION; CELL PROLIFERATION; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; ENZYME ACTIVATION; GENETIC LINKAGE; LYMPHOID CELL; NONHUMAN; ONCOGENE; PHOSPHORYLATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; ANIMAL; CELL DIVISION; CELL MOTION; CELL TRANSFORMATION; DRUG EFFECT; ERYTHROID PRECURSOR CELL; HUMAN; IMMUNOBLOTTING; LYMPHATIC LEUKEMIA; METABOLISM; MOUSE; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY; SERODIAGNOSIS;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; APOPTOSIS; CELL DIVISION; CELL MOVEMENT; CELL TRANSFORMATION, NEOPLASTIC; ERYTHROID PROGENITOR CELLS; FUSION PROTEINS, BCR-ABL; GRB2 ADAPTOR PROTEIN; GUANOSINE TRIPHOSPHATE; HELMINTH PROTEINS; HUMANS; IMMUNOBLOTTING; LEUKEMIA, LYMPHOCYTIC; MICE; MICE, KNOCKOUT; PHOSPHORYLATION; PRECIPITIN TESTS; PROTEINS; PYRIMIDINES; SIGNAL TRANSDUCTION; TYROSINE;

EID: 19044372472     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1535-6108(02)00074-0     Document Type: Article

References (64)

1. Auger, K.R., Serunian, L.A., Soltoff, S.P., Libby, P., and Cantley, L.C. (1989). PDGF-dependent tyrosine phosphorylation stimulates production of novel polyphosphoinositides in intact cells. Cell 57, 167-175.
2. Barthe, C., Cony-Makhoul, P., Melo, J.V., and Mahon, J.R. (2001). Roots of clinical resistance to STI-571 cancer therapy. Science 293, 2163a.
3. Ben-Neriah, Y., Daley, G.Q., Mes-Masson, A.M., Witte, O.N., and Baltimore, D. (1986). The chronic myelogenous leukemia-specific p210 protein is the product of the Bcr/Abl hybrid gene. Science 233, 212-214.
4. Chan, L.C., Karhi, K.K., Rayter, S.I., Heisterkamp, N., Eridani, S., Powles, R., Lawler, S.D., Groffen, J., Foulkes, J.G., Greaves, M.F., et al. (1987). A novel abl protein expressed in Philadelphia chromosome positive acute lymphoblastic leukaemia. Nature 325, 635-637.
5. Clark, S.S., McLaughlin, J., Crist, W.M., Champlin, R., and Witte, O.N. (1987). Unique forms of the abl tyrosine kinase distinguish Ph′-positive CML from Ph′-positive ALL. Science 235, 85-88.
6. Cortez, D., Kadlec, L., and Pendergast, A.M. (1995). Structural and signaling requirements for BCR-ABL-mediated transformation and inhibition of apoptosis. Mol. Cell. Biol. 15, 5531-5541.
7. Daly, R.J., Gu, H., Parmar, J., Malaney, S., Lyons, R.J., Kairouz, R., Head, D.R., Henshall, S.M., Neel, B.G., and Sutherland, R.L. (2002). The docking protein Gab2 is overexpressed and estrogen-regulated in breast cancer. Oncogene, in press.
8. Fainstein, E., Marcelle, C., Rosner, A., Canaani, E., Gale, R.P., Dreazen, O., Smith, S.D., and Croce, C.M. (1987). A new fused transcript in Philadelphia chromosome positive acute lymphocytic leukaemia. Nature 330, 386-388.
9. Gishizky, M.L., and Witte, O.N. (1992). Initiation of deregulated growth of multipotent progenitor cells by BCR-ABL in vitro. Science 256, 836-839.
10. Gishizky, M.L., Cortez, D., and Pendergast, A.M. (1995). Mutant forms of growth factor-binding protein-2 reverse BCR-ABL-induced transformation. Proc. Natl. Acad. Sci. USA 92, 10889-10893.
11. Goga, A., McLaughlin, J., Afar, D.E., Saffran, D.C., and Witte, O.N. (1995). Alternative signals to RAS for hematopoietic transformation by the BCR-ABL oncogene. Cell 82, 981-988.
12. Gorre, M.E., Mohammed, M., Ellwood, K., Hsu, N., Paquette, R., Rao, P.N., and Sawyers, C.L. (2001). Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification. Science 293, 876-880.
13. Gross, A.W., and Ren, R. (2000). Bcr-Abl has a greater intrinsic capacity than v-Abl to induce the neoplastic expansion of myeloid cells. Oncogene 19, 6286-6296.
14. Gu, H., Griffin, J.D., and Neel, B.G. (1997). Characterization of two SHP-2-associated binding proteins and potential substrates in hematopoietic cells. J. Biol. Chem. 272, 16421-16430.
15. Gu, H., Pratt, J.C., Burakoff, S.J., and Neel, B.G. (1998). Cloning of p97/ Gab2, the major SHP2-binding protein in hematopoietic cells, reveals a novel pathway for cytokine-induced gene activation. Mol. Cell 2, 729-740.
16. Gu, H., Maeda, H., Moon, J.J., Lord, J.D., Yoakim, M., Nelson, B.H., and Neel, B.G. (2000). New role for Shc in activation of the phosphatidylinositol 3-kinase/Akt pathway. Mol. Cell. Biol. 20, 7109-7120.
17. Gu, H., Saito, K., Klaman, L.D., Shen, J., Fleming, T., Wang, Y., Pratt, J.C., Lin, G., Lim, B., Kinet, J.P., and Neel, B.G. (2001). Essential role for Gab2 in the allergic response. Nature 412, 186-190.
18. He, Y., Wertheim, J.A., Xu, L., Miller, J.P., Karnell, F.G., Choi, J.K., Ren, R., and Pear, W.S. (2002). The coiled-coil domain and Tyr177 of bcr are required to induce a murine chronic myelogenous leukemia-like disease by bcr/abl. Blood 99, 2957-2968.
19. Heisterkamp, N., Stephenson, J.R., Groffen, J., Hansen, P.F., de Klein, A., Bartram, C.R., and Grosveld, G. (1983). Localization of the c-Abl oncogene adjacent to a translocation breakpoint in chronic myelocytic leukaemia. Nature 306, 239-242.
20. Heisterkamp, N., Stam, K., Groffen, J., de Klein, A., and Grosveld, G. (1985). Structural organization of the Bcr gene and its role in the Ph′ translocation. Nature 315, 758-760.
21. Herbst, R., Carroll, P.M., Allard, J.D., Schilling, J., Raabe, T., and Simon, M.A. (1996). Daughter of sevenless is a substrate of the phosphotyrosine phosphatase Corkscrew and functions during sevenless signaling. Cell 85, 899-909.
22. Hochhaus, A., Kreil, S., Corbin, A., La Rosee, P., Lahaye, T., Berger, U., Cross, N.C., Linkesch, W., Druker, B.J., Hehlmann, R., et al. (2001). Roots of clinical resistance to STI-571 cancer therapy. Science 293, 2163a.
23. Holgado-Madruga, M., Emlet, D.R., Moscatello, D.K., Godwin, A.K., and Wong, A.J. (1996). A Grb2-associated docking protein in EGF- and insulin-receptor signalling. Nature 379, 560-564.
24. Jain, S.K., Susa, M., Keeler, M.L., Carlesso, N., Druker, B., and Varticovski, L. (1996). PI 3-kinase activation in BCR/abl-transformed hematopoietic cells does not require interaction of p85 SH2 domains with p210 BCR/abl. Blood 88, 1542-1550.
25. Kurzrock, R., Shtalrid, M., Romero, P., Kloetzer, W.S., Talpas, M., Trujillo, J.M., Blick, M., Beran, M., and Gutterman, J.U. (1987). A novel c-abl protein product in Philadelphia-positive acute lymphoblastic leukaemia. Nature 325, 631-635.
26. Li, S., Ilaria, R.L., Jr., Million, R.P., Daley, G.Q., and Van Etten, R.A. (1999). The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity. J. Exp. Med. 189, 1399-1412.
27. Liu, Y., Jenkins, B., Shin, J.L., and Rohrschneider, L.R. (2001). Scaffolding protein Gab2 mediates differentiation signaling downstream of Fms receptor tyrosine kinase. Mol. Cell. Biol. 21, 3047-3056.
28. Lock, L.S., Royal, I., Naujokas, M.A., and Park, M. (2000). Identification of an atypical Grb2 carboxyl-terminal SH3 domain binding site in Gab docking proteins reveals Grb2-dependent and -independent recruitment of Gab1 to receptor tyrosine kinases. J. Biol. Chem. 275, 31536-31545.
29. Lynch, D.K., and Daly, R.J. (2002). PKB-mediated negative feedback tightly regulates mitogenic signalling via Gab2. EMBO J. 21, 72-82.
30. Mauro, M.J., O'Dwyer, M., Heinrich, M.C., and Druker, B.J. (2002). STI571: A paradigm of new agents for cancer therapeutics. J. Clin. Oncol. 20, 325-334.
31. McLaughlin, J., Chianese, E., and Witte, O.N. (1987). In vitro transformation of immature hematopoietic cells by the P210 BCR/ABL oncogene product of the Philadelphia chromosome. Proc. Natl. Acad. Sci. USA 84, 6558-6562.
32. McLaughlin, J., Chainese, E., and Witte, O.N. (1989). Alternative forms of the BCR/ABL oncogene have quantitatively different potencies for stimulation of immature lymphoid cells. Mol. Cell. Biol. 12, 1866-1874.
33. Million, R.P., and Van Etten, R.A. (2000). The Grb2 binding site is required for the induction of chronic myeloid leukemia-like disease in mice by the Bcr/Abl tyrosine kinase. Blood 96, 664-670.
34. Miyakawa, Y., Rojnuckarin, P., Habib, T., and Kaushansky, K. (2001). Thrombopoietin induces phosphoinositol 3-kinase activation through SHP2, Gab, and insulin receptor substrate proteins in BAF3 cells and primary murine megakaryocytes. J. Biol. Chem. 276, 2494-2502.
35. Nguyen, M.H., Ho, J.M., Beattie, B.K., and Barber, D.L. (2001). TEL-JAK2 mediates constitutive activation of the phosphatidylinositol 3′-kinase/protein kinase B signaling pathway. J. Biol. Chem. 276, 32704-32713.
36. Nieborowska-Skorska, M., Wasik, M.A., Slupianek, A., Salomoni, P., Kitamura, T., Calabretta, B., and Skorski, T. (1999). Signal transducer and activator of transcription (STAT)5 activation by BCR/ABL is dependent on intact Src homology (SH)3 and SH2 domains of BCR/ABL and is required for leukemogenesis. J. Exp. Med. 189, 1229-1242.
37. Nieborowska-Skorska, M., Slupianek, A., and Skorski, T. (2000). Progressive changes in the leukemogenic signaling in BCR/ABL- transformed cells. Oncogene 79, 4117-4124.
38. Nishida, K., Yoshida, Y., Itoh, M., Fukada, T., Ohtani, T., Shirogane, T., Atsumi, T., Takahashi-Tezuka, M., Ishihara, K., Hibi, M., and Hirano, T. (1999). Gab-family adapter proteins act downstream of cytokine and growth factor receptors and T- and B-cell antigen receptors. Blood 93, 1809-1816.
39. Ong, S.H., Dilworth, S., Hauck-Schmalenberger, I., Pawson, T., and Kiefer, F. (2001). ShcA and Grb2 mediate polyoma middle T antigen-induced endothelial transformation and Gab1 tyrosine phosphorylation. EMBO J. 20, 6327-6336.
40. Pane, F., Frigeri, F., Sindona, M., Luciano, L., Ferrara, F., Cimino, R., Meloni, G., Saglio, G., Salvatore, F., and Rotoli, B. (1996). Neutrophilic-chronic myeloid leukemia: a distinct disease with a specific molecular marker (BCR/ABL with C3/A2 junction). Blood 88, 2410-2414.
41. Pendergast, A.M., Quilliam, L.A., Cripe, L.D., Bassing, C.H., Dai, Z., Li, N., Batzer, A., Rabun, K.M., Der, C.J., and Schlessinger, J. (1993). BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein. Cell 75, 175-185.
42. Pratt, J.C., Igras, V.E., Maeda, H., Baksh, S., Gelfand, E.W., Burakoff, S.J., Neel, B.G., and Gu, H. (2000). Gab2 mediates an inhibitory phosphatidylinositol 3′- kinase pathway in T cell antigen receptor signaling. J. Immunol. 165, 4158-4163.
43. Puil, L., Liu, J., Gish, G., Mbamalu, G., Bowtell, D., Pelicci, P.G., Arlinghaus, R., and Pawson, T. (1994). Bcr-Abl oncoproteins bind directly to activators of the Ras signalling pathway. EMBO J. 13, 764-773.
44. Quackenbush, R.C., Reuther, G.W., Miller, J.P., Courtney, K.D., Pear, W.S., and Pendergast, A.M. (2000). Analysis of the biologic properties of p230 Bcr-Abl reveals unique and overlapping properties with the oncogenic p185 and p210 Bcr-Abl tyrosine kinases. Blood 95, 2913-2921.
45. Raabe, T., Riesgo-Escovar, J., Liu, X., Bausenwein, B.S., Deak, P., Maroy, P., and Hafen, E. (1996). DOS, a novel pleckstrin homology domain-containing protein required for signal transduction between sevenless and Ras1 in Drosophila. Cell 85, 911-920.
46. Roumiantsev, S., de Aos, I.E., Varticovski, L., Ilaria, R.L., and Van Etten, R.A. (2001). The src homology 2 domain of Bcr/Abl is required for efficient induction of chronic myeloid leukemia-like disease in mice but not for lymphoid leukemogenesis or activation of phosphatidylinositol 3-kinase. Blood 97, 4-13.
47. Sakai, N., Ogiso, Y., Fujita, H., Watari, H., Koike, T., and Kuzumaki, N. (1994). Induction of apoptosis by a dominant negative H-RAS mutant (116Y) in K562 cells. Exp. Cell Res. 215, 131-136.
48. Salgia, R., Quackenbush, E., Lin, J., Souchkova, N., Sattler, M., Ewaniuk, D.S., Klucher, K.M., Daley, G.Q., Kraeft, S.K., Sackstein, R., et al. (1999). The BCR/ABL oncogene alters the chemotactic response to stromal-derived factor-1 alpha. Blood 94, 4233-4246.
49. Sattler, M., Salgia, R., Okuda, K., Uemura, N., Durstin, M.A., Pisick, E., Xu, G., Li, J.L., Prasad, K.V., and Griffin, J.D. (1996). The proto-oncogene product p120CBL and the adaptor proteins CRKL and c-CRK link c-ABL, p190BCR/ABL and p210BCR/ABL to the phosphatidylinositol-3′ kinase pathway. Oncogene 12, 839-846.
50. Sawyers, C.L., Mclaughlin, J., and Witte, O.N. (1995). Genetic requirement for ras in the transformation of fibroblasts and hematopoietic cells by the bcr-abl oncogene. J. Exp. Med. 181, 307-313.
51. Schaeper, U., Gehring, N.H., Fuchs, K.P., Sachs, M., Kempkes, B., and Birchmeier, W. (2000). Coupling of Gab1 to c-Met, Grb2, and Shp2 mediates biological responses. J. Cell Biol. 149, 1419-1432.
52. Schwaller, J., Parganas, E., Wang, D., Cain, D., Aster, J.C., Williams, I.R., Lee, C.K., Gerthner, R., Kitamura, T., Frantsve, J., et al. (2000). Stat5 is essential for the myelo- and lymphoproliferative disease induced by TEL/JAK2. Mol. Cell 6, 693-704.
53. Senechal, K., Halpern, J., and Sawyers, C.L. (1996). The CRKL adaptor protein transforms fibroblasts and functions in transformation by the BCR-ABL oncogene. J. Biol. Chem. 271, 23255-23261.
54. Sexl, V., Piekorz, R., Moriggl, R., Rohrer, J., Brown, M.P., Bunting, K.D., Rothammer, K., Roussel, M.F., and Ihle, J.N. (2000). Stat5a/b contribute to interleukin 7-induced B-cell precursor expansion, but abl- and bcr/abl-induced transformation are independent of stat5. Blood 96, 2277-2283.
55. Shtivelman, E., Lifshitz, B., Gale, R.P., and Canaani, E. (1985). Fused transcript of abl and bcr genes in chronic myelogenous leukaemia. Nature 315, 550-554.
56. Skorski, T., Kanakaraj, P., Nieborowskaskorska, M., Ratajczak, M.Z., Wen, S.C., Zon, G., Gewirtz, A.M., Perussia, B., and Calabretta, B. (1995). Phosphatidylinositol-3 kinase activity is regulated by bcr/abl and is required for the growth of Philadelphia chromosome-positive cells. Blood 86, 726-736.
57. Skorski, T., Bellacosa, A., Nieborowska-Skorska, M., Majewski, M., Martinez, R., Choi, J.K., Trotta, R., Wlodarski, P., Perrotti, D., Chan, T.O., et al. (1997). Transformation of hematopoietic cells by BCR/ABL requires activation of a PI-3k/Akt-dependent pathway. EMBO J. 16, 6151-6161.
58. Tauchi, T., Feng, G.S., Shen, R., Song, H.Y., Donner, D., Pawson, T., and Broxmeyer, H.E. (1994). SH2-containing phosphotyrosine phosphatase syp is a target of p210bcr-abl tyrosine kinase. J. Biol. Chem. 269, 15381-15387.
59. Walker, L.C., Ganesan, T.S., Dhut, S., Gibbons, B., Lister, T.A., Rothbard, J., and Young, B.D. (1987). Novel chimaeric protein expressed in Philadelphia positive acute lymphoblastic leukaemia. Nature 329, 851-853.
60. Wickrema, A., Uddin, S., Sharma, A., Chen, F., Alsayed, Y., Ahmad, S., Sawyer, S.T., Krystal, G., Yi, T., Nishada, K., et al. (1999). Engagement of Gab1 and Gab2 in erythropoietin signaling. J. Biol. Chem. 274, 24469-24474.
61. Wolf, I., Jenkins, B.J., Liu, Y., Seiffert, M., Custodio, J.M., Young, P., and Rohrschneider, L.R. (2002). Gab3, a new DOS/Gab family member, facilitates macrophage differentiation. Mol. Cell. Biol. 22, 231-244.
62. Yamasaki, S., Nishida, K., Hibi, M., Sakuma, M., Shiina, R., Takeuchi, A., Ohnishi, H., Hirano, T., and Saito, T. (2001). Docking protein Gab2 is phosphorylated by ZAP-70 and negatively regulates T cell receptor signaling by recruitment of inhibitory molecules. J. Biol. Chem. 276, 45175-45183.
63. Zhang, X., Subrahmanyam, R., Wong, R., Gross, A.W., and Ren, R. (2001). The NH(2)-terminal coiled-coil domain and tyrosine 177 play important roles in induction of a myeloproliferative disease in mice by Bcr-Abl. Mol. Cell. Biol. 21, 840-853.
64. Zhao, C., Yu, D.H., Shen, R., and Feng, G.S. (1999). Gab2, a new pleckstrin homology domain-containing adapter protein, acts to uncouple signaling from ERK kinase to Elk-1. J. Biol. Chem. 274, 19649-19654.